alirocumab

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels
24/7 Wall St
Sun, 06/7/15 - 10:57 am
FDA
advisory panels
Regeneron
AbbVie
Amgen
Repatha
alirocumab
PCSK9 inhibitors
FDA staff: Sanofi/Regeneron drug lowers LDL; is well tolerated
Yahoo/Reuters
Fri, 06/5/15 - 09:20 am
FDA
Sanofi
Regeneron
alirocumab
advisory panels
More Preliminary Signs That The New Cholesterol Drugs May Improve Outcomes
Forbes
Tue, 04/28/15 - 08:45 am
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
alirocumab
evolocumab
Amgen, Regeneron Stocks Go Up as Drugs Bring Cholesterol Down
Forbes
Tue, 03/17/15 - 08:47 am
Amgen
Regeneron
PCSK9 inhibitors
alirocumab
evolocumab
New Cholesterol Drugs: Highly Effective But Important Questions Remain
Forbes
Mon, 03/16/15 - 09:08 am
PCSK9 inhibitors
alirocumab
evolocumab
Amgen
Sanofi
Regeneron
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Sanofi
Regeneron
Amgen
alirocumab
evolocumab
PCSK9 inhibitors
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Sanofi, Regeneron cholesterol drug also effective in monthly doses
Yahoo/Reuters
Fri, 01/9/15 - 08:03 am
Sanofi
Regeneron
alirocumab
5 Potential Blockbuster Drugs Set To Launch In 2015
Investors.com
Thu, 01/8/15 - 08:15 am
Amgen
Regeneron
evolocumab
alirocumab
Alexion
asfotase alfa
Novartis
LCZ696
Pfizer
palbociclib
Regeneron drug highly effective for those who can't take statins: study
Reuters
Tue, 11/18/14 - 03:49 pm
Regeneron
statins
Sanofi
alirocumab
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement
Yahoo
Fri, 10/17/14 - 09:56 am
Amgen
Sanofi
Regeneron
patents
alirocumab
monoclonal antibodies
evolocumab
Regeneron touts its allergy drug as a blockbuster in waiting
Fierce Biotech
Mon, 09/22/14 - 09:37 am
Regeneron
allergy
alirocumab
dupilumab
Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
Yahoo/PR Newswire
Sun, 08/31/14 - 09:56 am
Sanofi
Regeneron
alirocumab
hypercholesterolemia
As race to market intensifies, how expectant are cardiologists for PCSK9 inhibitor class?
First Word Pharma
Wed, 08/6/14 - 10:11 am
cardiologists
physicians
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
evolocumab
alirocumab
Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials
Yahoo/Reuters
Wed, 07/30/14 - 09:02 am
cholesterol
Sanofi
Regeneron
alirocumab
New Cholesterol Fighters To Take Center Stage At ACC
Investors.com
Fri, 03/28/14 - 10:22 am
cholesterol
Pfizer
Amgen
Regeneron
Sanofi
PCSK9 inhibitors
American Cardiology Conference
alirocumab
FDA Concerns Are the Least of These Drugs' Worries
Motley Fool
Mon, 03/17/14 - 09:53 am
FDA
PCSK9 inhibitors
Regeneron
Sanofi
Merck
alirocumab
FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
Yahoo/Reuters
Fri, 03/7/14 - 03:55 pm
Sanofi
FDA
Regeneron
alirocumab
PCSK9 inhibitors
Sanofi to tap ACC registry for cardiovascular clinical trial
Yahoo/Reuters
Thu, 12/19/13 - 08:09 am
Sanofi
clinical trials
alirocumab
American College of Cardiology
3 New Cholesterol Treatments Worth Watching
Motley Fool
Sun, 11/24/13 - 12:46 pm
Sanofi
Regeneron
Amgen
alirocumab
AMG 145
RN-316
Pfizer

Pages